Cell Biotech Market Cap

Cell Biotech has a market cap or net worth of 93.08 billion as of March 9, 2026. Its market cap has decreased by -1.81% in one year.

Market Cap

93.08B

Enterprise Value

4.70B

Revenue

50.65B

Ranking

n/a

PE Ratio

7.39

Stock Price

14,070.00

Market Cap Chart

Since March 3, 2003, Cell Biotech's market cap has increased from 13.97B to 93.08B, an increase of 566.36%. That is a compound annual growth rate of 8.59%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	96.29B	7.32%
Dec 30, 2025	89.72B	-8.13%
Dec 30, 2024	97.66B	27.18%
Dec 28, 2023	76.79B	-11.65%
Dec 29, 2022	86.92B	-34.80%
Dec 30, 2021	133.30B	-19.84%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CTCBIO	95.52B
Progen	100.55B
KoBioLabs	90.69B
TegoScience	103.44B
Quratis	103.62B
Parataxis Korea	87.62B
Choong Ang Vaccine Laboratory	87.30B
IMGT Co.,Ltd.	106.96B

Market Cap Rankings